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 Hereditary degenerative diseases of the retina lead to pro-
gressive death of rod and subsequently cone photoreceptors
by apoptosis [1]. Improved understanding of the pathological
process of these diseases would lead to the effective therapies
to delay or ameliorate photoreceptor cell death. The rds mice
is homozygous for a null mutation in the prph 2 gene, which
encodes a transmembrane glyco-protein peripherin 2, which
is essential for the formation and maintenance of normal pho-
toreceptor outer segment. Consequently, the rds mice failed
to develop photoreceptor outer segments and underwent pro-
gressive loss of photoreceptors by apoptosis [1,2]. In humans,
over 10 different retinal phenotypes have been associated with
mutations in the peripherin gene, including autosomal domi-
nant retinitis pigmentosa (RP) and macular dystrophies
(RetNet).
In the recent decade, increasing attention has been fo-
cused on the pathogenic role of microglia in retinal degenera-
tions. Accompanying photoreceptor degenerations in Royal
College of Surgeons (RCS) rat, rd mice, and light-induced
retinal degeneration mice, microglia was activated and mi-
grated from inner retinal layer (IRL) to outer nuclear layer
(ONL) [3-6]. Recently, Hughes et al. observed that accompa-
nying photoreceptor degeneration in rds mice, microglia pro-
liferated and migrated to the subretinal space, which confirmed
the intimate association between activated microglia and the
degenerative process in this animal model [7,8]. However the
sequential relationship between microglial activation and pho-
toreceptor apoptosis had not been fully elucidated. The induc-
ible nitric oxide synthase (iNOS), previously isolated from
murine macrophage [9], is expressed in many cell types espe-
cially activated microglia, and induces the release of nitric
oxide (NO) over long periods [10,11]. The production of NO
was a major factor for tissue damage after activation of mi-
croglia. Previous studies had shown that microglial derived
NO played an important role in the pathogenesis of brain is-
chemia [12] and experimental autoimmune uveitis [13]. Two
things should be considered: (1) The possibility that iNOS
might take part in the retinal degenerative process in rds mice;
and (2) the co-relationship between activated microglia and
iNOS expression.
Minocycline is, a semi-synthetic, long-acting tetracycline
derivative that has good penetration of the blood-brain bar-
rier. It has recently been shown to have remarkable
neuroprotective properties in models of neurodegeneration
[14], brain ischemia [12], Parkinson’s disease [15], and mul-
tiple sclerosis [16]. Previous studies have demonstrated that
minocycline treatment decreased the expression of iNOS [12]
and microglial activation [17]. Recently, Hughes et al. observed
that minocycline delayed photoreceptor apoptosis in rds mice
[8]. The possibility that minocycline may exert its protective
effect through iNOS-suppressive or microglial-suppressive
mechanisms must be considered.
In the present study, we investigated the sequential events
of photoreceptor apoptosis, microglial activation, and iNOS
expression in rds mice. We also examined the protective ef-
fect and possible mechanisms of minocycline on the retinal
degeneration process in rds mice.
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Purpose: To elucidate the role of activated microglia and nitric oxide (NO) in photoreceptor apoptosis in rds mice, and to
investigate the effect of minocycline treatment on rds mice.
Methods: Photoreceptor apoptosis in rds mice was detected by terminal dUTP transferase nick end labeling (TUNEL).
Retinal microglial cells were identified by CD11b antibody. The mRNA expression of inducible nitric oxide synthase
(iNOS) and chemokines were examined by reverse transcription polymerase chain reaction (RT-PCR) assay. The protein
expression of iNOS was examined by immunohistochemistry and Western blotting analysis. The rds mice were treated
intra-peritoneally from the second postnatal day (P2) with minocycline.
Results: Accompanying photoreceptor degeneration in rds mice, microglia were activated and immigrated from inner
retinal layer (IRL) to outer nuclear layer (ONL), and the expression of iNOS was up-regulated. Minocycline treatment
reduced the iNOS expression and decreased the initial photoreceptor apoptosis, but did not provide long term ameliorative
effect on the photoreceptor cell loss of rds mice.
Conclusions: NO played a major role in the initial photoreceptor apoptosis in rds mice. The migration of activated
microglia to the ONL contributed to the subsequent photoreceptor cell death; minocycline treatment ameliorated the
photoreceptor apoptosis in rds mice, and this protective effect was partly through iNOS-suppressive mechanism.
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Animals and procedures:  All experiments were performed in
accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research. All animals were
husbanded in according with the guidelines of the Associa-
tion for the Assessment and Accreditation of Laboratory Ani-
mal Care. Prph2Rd2/Rd2 and normal control C3B mice
(C3.BliAPdeb-rd1) were obtained from Jackson Laboratories (Bar
Harbor, ME), and were housed under specific pathogen-free
conditions in the Animal Facility of Peking University Health
Science Center. They were housed in an air-conditioned room
with a 12:12 h light-dark cycle at a light intensity of 20 to 40
lux.
Minocycline hydrochloride (Sigma-Aldrich, St. Louis,
MI) 50 mg/kg was injected intra-peritoneally into mice daily
from the second postnatal day (P2) until P14, P17, P21, and
P28. At least five animals and controls were used per group. A
total of about one thousand mice were used.
Tissue preparation:  Animals were euthanized with an
overdose of pentobarbital, and their eyes were immediately
enucleated and fixed in 4% (w/v) paraformaldehyde (PFA) in
PBS for 1 h. The anterior segments were removed and the
posterior segments were further fixed in the same fixative for
an additional period of 5 h. The tissue samples were trans-
ferred to 20% sucrose buffer overnight at 4 °C for
cryoprotection and then embedded in OCT compound. Fro-
zen sections were cut 8 µm thick through the optic nerve head
and ora serrata with a cryostat, and the sections were kept in a
-80 °C freezer until use.
Retinal wholemounts were prepared by bisecting the eyes
at the ciliary body into anterior and posterior sections. The
lens and vitreous were removed, and the retina was subse-
quently separated from the underling retinal pigment epithe-
lium and choroid. Wholemount retinas were kept in a 4 °C
freezer until use.
Morphometric studies:  The mouse retinas treated with
or without minocycline were examined in hematoxylin and
eosin-stained sections by light microscopy. For measurement
of the ONL thickness, only sections passing through the optic
nerve head were analyzed. Nine sections from three mice were
analyzed and measurements were taken 300 µm from the op-
tic nerve head on both sides.
TUNEL studies:  Photoreceptor apoptosis was assessed
using a DeadEnd™ Colorimetric TUNEL System (Promega
Corporation, Madison, WI) according to manufacturers’ pro-
tocol. TUNEL-positive photoreceptor cells were counted by a
blind observer. Positive-stained apoptotic photoreceptors were
counted in a standard length of retina (1.2 mm) centered on
the optic nerve head using a graticule at 40 objective magnifi-
cation following a technique as described in reference [7]. Nine
sections from three mice were used for TUNEL studies.
Immunohistochemistry studies:  Experiments were car-
ried out using appropriate positive and negative controls (no
primary antibody). CD11b was used for the detection of mi-
croglia, is an antigen containing two polypeptides of 170 kDa
and 95 kDa found on the surface of mouse macrophages with
unknown function.
Tissue sections were fixed in chilled fresh acetone for 10
min, and were successively incubated with 0.3% H2O2 in
methanol for 15 min, blocking reagents for 10 min, primary
antibodies to CD11b (1:50, Serotec Ltd., Oxford, UK) or to
iNOS (1:100, Santa Cruz Biotechnology, CA) at 4 °C over-
night, corresponding biotinylated secondary antibodies for 45
min, horseradish peroxidase (HRP) avidin-biotin complex for
30 min and developed with DAB.
Wholemount retinas were fixed in absolute ethanol for
10 min at 4 °C, re-hydrated in 0.01 M PBS for 20 min, and
made permeable by incubating in 1% Triton X-100 contain-
ing 1% bovine serum albumin for 1 h, then incubated in pri-
mary antibodies to CD11b (1:50 dilution) or to iNOS (1:100
dilution) at 4 °C overnight. Afterwards the retinas were incu-
bated with corresponding biotinylated secondary antibodies
and HRP avidin-biotin complex for 3 h at 37 °C, respectively,
and developed with DAB. Retinal wholemounts were exam-
ined by confocal microscope and counted by blinded observ-
ers. Positively stained microglia in the ONL were counted in
a standard area of retina using a graticule at 40 objective mag-
nification. At least ten non-adjacent areas per eye were counted
for each stain.
Total RNA extraction and semiquantitative reverse tran-
scription:  A semiquantitative reverse transcription polymerase
chain reaction (RT-PCR) assay was performed to measure the
expression levels of chemokine mRNA transcripts in the whole
retina. The eyes were enucleated and bisected. The retinas were
peeled from the eyecup and immediately homogenized in the
extraction Trizol reagent (Invitrogen Corporation, Grand Is-
land, NY). Total RNA was isolated by chloroform extraction
and isopropanol precipitation according to the manufacturer’s
instructions. Reverse transcription was performed with oligo-
nucleotide primers using Superscript™ reverse transcriptase
(Invitrogen) according to manufacturer’s protocol. Afterwards
PCR was performed. The primers and annealing temperature
are shown in Table 1. Each PCR product was separated on 2%
agarose gel and analyzed with Quantity One 1-D Analysis
Software (Bio-Rad, Richmond, CA). The amount of RT-PCR
products was corrected with β-actin expression. Because of
the wide variation in expression levels of these genes, we used
different cycles to obtain optimum expression. The levels of
expression were then compared within the time course for one
particular gene mRNA, but were not compared between genes.
PCR experiments were repeated at least four times.
Western blotting analysis:  The eyes were enucleated and
bisected. The retinas were peeled from the eyecup and imme-
diately homogenized with 0.5 ml ice-cold lysis buffer [50 mM
Tris-CL pH 8.0, 0.02% sodium azide, 1 µg/ml aprotinin, 1%
NP-40, 100 µg/ml phenylmethylsulfonyl fluoride (PMSF)].
Insoluble material was removed by centrifugation at 120,000
rpm at 4 °C for 20 min. Final protein concentrations were de-
termined using the BCA protein assay kit (Pierce Biotechnol-
ogy, Rockford, IL) according to the manufacturer’s specifica-
tions. Western blotting analysis was then performed accord-
ing to a technique described in reference [18]. The antibody
to iNOS, (1:1000 dilution in blocking solution) was used for
immunodetection, and an anti-ERK2 polyclonal antibody was
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1074used to serve as a control to ensure that equivalent quantities
of proteins were used for SDS-PAGE. Protein bands were digi-
tally analyzed with Quantity One 1-D Analysis Software (Bio-
Rad). The Western blotting experiments were repeated at least
for four times.
Statistical analysis:  Data were presented as the mean±SD.
An independent sample t-test was used to determine statisti-
cal significance. A p<0.01 was considered significant.
RESULTS
Photoreceptor apoptosis in rds mice:  No TUNEL-positive
photoreceptor cells were observed in the ONL of the normal
control C3B retina at P14. In rds mice, few TUNEL-positive
cells were initially detected in the ONL at P14. At P17 the
number of TUNEL-positive photoreceptor cells reached a peak.
After P21 only scattered TUNEL-positive photoreceptor cells
were observed. The time course of the increment and reduc-
tion of the TUNEL-positive photoreceptor cells in the ONL in
rds retina are illustrated in Figure 1.
Microglial activation in rds mice:  Two subpopulations
of CD11b-labeled microglial cells were identified in normal
control C3B retina. One subpopulation had long-, slender pro-
cesses, localized at the perivascular region in the neural fiber
layer and the ganglion cell layer (Figure 2A). The other, with
short wide processes, was mostly found in the retinal paren-
chyma, did not run along the retinal vessels and was more
localized in the inner plexiform layer (Figure 2B). No micro-
glial cells were identified in ONL in the normal control C3B
retina (Figure 2C). In the rds mice before P14, the number
and distribution of the microglial cells were comparable to
those in the normal control C3B retina. However at P17, the
microglial cells were first noted in the ONL in the rds retina
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TABLE 1. OLIGONUCLEOTIDES USED FOR REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
Primers were designed using the Primer Express Program and purchased from AuGCT Biotechnology, Beijing, P. R. China.
Figure 1. Temporal relationship between photoreceptor apoptosis and
CD11b-labeled microglial cells in the outer nuclear layer of rds mouse
retina.  The number of TUNEL-positive photoreceptor cells peaked
at P17, which was significantly higher than at P14 and P21. At P17
the activated mciroglia was first presented in the outer nuclear layer
(ONL). At P28 the number of activated mciroglia in the ONL reached
a peak, which was significantly higher than at P21 and P42. Data
were expressed as mean±SD. A p<0.01 (*) was considered signifi-
cant compared with P14 and P21 in TUNEL studies. A p<0.01 (hash
mark) was considered significant compared with P21 and P42 in
microglial studies.
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Figure 2. Immunohistochemical labeling of CD11b-positive microglial cells in retinal whole-mounts on control and rds mice.  A-C: Normal
control C3B mouse retina at P28: (A) In the inner retinal layer, microglia had long, thin processes, located in the peri-vascular region (arrows);
(B) In the middle retinal layer, microglia were ramified with short, wide processes. Most cells were vessel-independent (arrows); (C) In the
outer nuclear layer (ONL), no microglial cells were identified. D-F: Microglial cells in ONL of rds mice. The cells were ameboid with few
stout processes (arrows): (D): At P17, microglial cells were initially present in the ONL; (E): By P28, the number of microglial cells in the
ONL had reached their peak; (F): At P180, few microglial cells were scattered in the ONL. (Magnification x400).
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(Figure 2D). At P28 the number of microglial cells in ONL
reached a peak (Figure 2E). After P42 the microglial cells in
the ONL were reduced in number. By P180, only a few micro-
glial cells scattered among the ONL (Figure 2F). The micro-
glial cells in the ONL were characteristically ameboid with
few stout processes (Figure 2D-F). The temporal relationship
of the increment and reduction of activated microglia in the
ONL with the photoreceptor apoptosis in rds retina is illus-
trated in Figure 1.
The expression of iNOS in rds retina:  The expressions of
iNOS in rds retina were determined by RT-PCR, Western blot-
ting, and immunohistochemistry studies. A representative gel
image of iNOS mRNA expression is shown in Figure 3A-B.
The results showed that normal control C3B retina constitu-
tively expressed detectable quantities of mRNA transcripts for
iNOS. Accompanying photoreceptor degenerations in rds mice,
the iNOS mRNA expression was up-regulated in a time de-
pendent manner. The expression of iNOS mRNA was up-regu-
lated from P12 and, peaked at P14. The expression slowly
declined, and by P90 the expression returned to the basal level.
A representative image of iNOS protein expression was
shown in Figure 3C-D. The results showed that normal con-
trol C3B retina constitutively expressed detectable quantities
of iNOS protein. The expression of iNOS protein in rds retina
at each age group paralleled the result of iNOS mRNA ex-
pression.
Location of iNOS protein expression was determined by
immunohistochemistry study. Our study indicated that iNOS
immunoreactivity was not observed in the normal control C3B
retina (Figure 4A). In rds retina, the iNOS immunoreactivity
was restricted to the photoreceptor outer segments (Figure 4B).
Double labeling of iNOS and CD11b at the peak of microglial
activation showed that iNOS was not expressed in activated
microglia.
Expression of chemokines in rds retina:  Relative levels
of mRNA transcripts for chemokines MCP-1, MCP-3, MIP-
1α, MIP-1β, RANTES and eotaxin were measured by semi-
quantitative RT-PCR at various time points. A representative
gel image is shown in Figure 5. The results showed that nor-
mal control C3B retina expressed low levels of mRNA tran-
scripts for MCP-1, MCP-3, MIP-1α and MIP-1β, but expressed
modest quantities of RANTES and eotaxin. In rds retina, the
expression of mRNA transcripts for MCP-1, MCP-3, MIP-
1α, MIP-1β, RANTES, and eotaxin was up-regulated when
compared with the normal control. The expression of MIP-
1α, MIP-1β and RANTES were up-regulated from P12,
reached a peak at P17, and had declined to their basal levels
by P28. The expressions of MCP-1, MCP-3, and eotaxin were
up-regulated from P14 and, reached a peak at P28. After that
time their expressions slowly declined, and by P180 had de-
creased to the basal level.
Minocycline treatment reduced photoreceptor apoptosis
and iNOS expression in rds mice:  Minocycline-treated retina
harbored a thicker ONL and, was composed of more rows of
photoreceptor nuclei than un-treated retina at P17, P21, and
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Figure 4. Immunohistochemical labeling of iNOS protein in control and rds mice retinas.  A: At P14 in C3B mice, there was no iNOS-positive
staining seen. B: At P14 in rds mice, iNOS-positive staining was mainly located at the photoreceptor outer segment (arrows). ONL represents
outer nuclear layer; OS represents outer segment. (Magnification x400).
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Figure 3. The iNOS mRNA and protein expression in control and rds mice retinas.  A: Time course for iNOS mRNA expression in control and
rds retinas for each age group. B: The relative levels of iNOS mRNA expression in rds mice were quantified and corrected for the level of β-
actin mRNA expression. C: Time course for iNOS protein expression in control and rds retinas at each age group. D: The relative level of
iNOS protein expression in rds mice were quantified and corrected for the levels of ERK2 protein expression. NC, P14 C3B mice. A p<0.01
(*) was considered significant compared with the normal control retina.©2007 Molecular Vision Molecular Vision 2007; 13:1073-82 <http://www.molvis.org/molvis/v13/a117/>
Figure 5. Retinal expression of chemokines in rds mice.  A: The elec-
trophoresis pattern of RT-PCR products for chemokines MCP-1,
MCP-3, MIP-1β, MIP-1α, RANTES, and eotaxin in control and rds
mice retinas. B: The time-course for chemokine mRNA expression
in rds retina. The relative levels of mRNA were expressed as a ratio
to that of β-actin. NC, P14 C3B mice. A p<0.01 (*) was considered
significant compared with the normal control retina.
1078P28; however, the difference was statistically significant at
P21 (Figure 6A).
Photoreceptor apoptosis peaked at P17 in minocycline-
treated and un-treated retinas. TUNEL-positive cells in the
ONL were counted to obtain an estimate of the difference in
photoreceptor apoptosis between the minocycline-treated
retina and untreated controls. At P14, a few TUNEL-positive
cells were detected both in minocycline-treated and un-treated
retinas. The difference was statistically insignificant. At P17,
the retinal sections from the minocycline-treated eyes displayed
roughly 30% fewer TUNEL-positive photoreceptors than the
un-treated controls. The difference was statistically signifi-
cant. At P21, the retinal sections from the minocycline-treated
eyes displayed fewer TUNEL-positive photoreceptors than the
un-treated control eyes, but the difference was statistically
insignificant. At P28, the TUNEL-positive cells in
minocycline-treated eyes greater than that in the un-treated
controls, and the difference was statistically insignificant. The
time course of the increment and reduction of the TUNEL-
positive cells in minocycline-treated and un-treated retinas is
illustrated in Figure 6B.
To further examine whether minocycline treatment re-
duced the photoreceptor apoptosis via microglial suppressive
mechanism, we investigated the effect of minocycline on the
number of activated microglia in the ONL. The results showed
that minocycline treatment had no significant effect on mi-
croglial activation in rds retina (Figure 6C).
To further examine whether minocycline treatment re-
duced the photoreceptor apoptosis via suppression of iNOS
expression, we examined the effect of minocycline on the iNOS
mRNA and protein expression in rds mice. Semiquantitative
RT-PCR analysis showed that administration of minocyline
produced a significantly reduction in the expression of iNOS
mRNA by approximately 75% and 66% at P14 and P17, re-
spectively (Figure 7A-B). Western blotting analysis showed
that administration of minocyline produced a significant re-
duction in the expression of iNOS protein by approximately
72% and 68% at P14 and P17, respectively (Figure 7C-D).
DISCUSSION
 Our studies demonstrated a temporal relationship involving
photoreceptor apoptosis, microglial activation, iNOS expres-
sion, and chemokine expression during the retinal degenera-
tive process in rds mice. Photoreceptor apoptosis started at
P14 and peaked at P17. Retinal microglia were activated and
infiltrated ONL at P17, which was three days after the initia-
tion of photoreceptor apoptosis, and peaked at P28, which was
11 days after the peak of photoreceptor apoptosis. The up-
regulation of iNOS expression was preceded the photorecep-
tor apoptosis. At the peak of iNOS expression, iNOS was pre-
dominantly expressed in photoreceptor outer segment. Expres-
sion of chemokines MCP-1, MCP-3, MIP-1α, MIP-1β,
RANTES and eotaxin were up-regulated during the retinal
degenerative process. Minocycline treatment reduced the iNOS
expression and delayed the initial photoreceptor apoptosis, but
in the late stage of the disease, microglial activation and pho-
toreceptor apoptosis persisted.
The aforedescribed sequential events suggest that NO
might play an important role in the initial photoreceptor
apoptosis. The microglial activation followed closely with the
apoptotic process of the photoreceptors. However the initia-
tion of photoreceptor apoptosis preceded microglial activa-
tion. So, microglia was not likely to be the initial instigator
for rod apoptosis, but might influence the subsequent cone
cell death in rds mice. Minocycline played its photoreceptor
protective role partly through iNOS-dependent mechanism.
©2007 Molecular Vision Molecular Vision 2007; 13:1073-82 <http://www.molvis.org/molvis/v13/a117/>
Figure 6. Minocycline delayed the photoreceptor apoptosis in rds
mice.  A: The retinal sections from the minocycline-treated rds eyes
harbored a thicker outer nuclear layer (ONL). The difference was
statistically significant at P21. B: The retinal sections from the
minocycline-treated rds eyes displayed roughly 30% fewer TUNEL
labeling at P17 than un-treated eyes. The difference was statistically
significant, however the difference was statistically insignificant at
P21. At P28, the number of TUNEL-positive cells in the minocycline-
treated retina was more than those in the un-treated retina. The dif-
ference was statistically insignificant. C: Minocycline treatment had
no significant effect on the number of ONL microglia in rds retina.
Data were expressed as mean±SD. A p<0.01 (*) was considered sig-
nificant compared with the age-paired un-treated retina.
1079We hypothesized that the initial gene defect in peripherin/RDS
would result in the developmental disorder of photoreceptor
outer segment, induce the high expression of iNOS, and se-
crete high levels of NO and induced the initial rod photore-
ceptor apoptosis. The apoptotic photoreceptors produced
chemokines to activate and recruit retinal microglia to the le-
sion site. However the accumulation of activated microglia in
the ONL not only cleared the debris, but also secreted cyto-
toxic factors to exaggerate subsequent cone photoreceptor
death.
It is known that a low level of NO is an important media-
tor of homeostatic processes in the eye, such as regulation of
aqueous humor dynamics [19], retinal neurotransmission [20]
and photo-transduction [21]. However the production of NO
at higher concentrations are toxic to the neurons [22,23]. A
number of pathways could be involved in the NO-induced pho-
toreceptor degenerative process, such as the following: (1) NO
might act by eliciting a cGMP increase in the photoreceptor
cells leading to excess calcium influx [21]; (2) NO could ADP-
ribosilate certain photoreceptor proteins and modulate their
activity [24]; and (3) NO could also act as a free radical ca-
pable of combining with oxygen derivatives, resulting in the
production of the peroxynitrite anion ONOO-, which is highly
cytotoxic [25]. In the present study the iNOS expression was
up-regulated in rds mice, and its up-regulation was preceded
the photoreceptor apoptosis. We propose that NO might play
an important role in the initial retinal degeneration in rds mice.
Previous studies on RCS rat and rd mice suggested that
activated microglia, having migrated to the photoreceptor layer
in response to the debris buildup in the subretinal space or
photoreceptor dysfunction, might be the instigator of photo-
receptor apoptosis [3,5]. In our present study on rds mice, by
closely scrutinized the temporal relationship between photo-
receptor apoptosis and microglial activation, we found that
the photoreceptor apoptosis was preceded the microglial acti-
vation. This was consistent with the findings by Hughes et al
[8]. In addition, minocycline treatment ameliorated the initial
photoreceptor apoptosis at P17, at which point activated mi-
croglia was first presented in ONL. This event, but had no
effect on the subsequent photoreceptor apoptosis at P28, at
which time activated microglia in ONL reached its peak. We
suggest that activated microglia is innocent in the initial pho-
toreceptor apoptosis, but might be responsible for the subse-
quent photoreceptor apoptosis.
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Figure 7. The iNOS mRNA and protein expression in minocycline-treated and un-treated rds mice.  A, B: Minocycline treatment reduced the
iNOS mRNA expression in rds mice at P14 and P17. The difference was statistically significant; C, D: Minocycline treatment reduced the
iNOS protein expression in rds mice at P14 and P17, and the difference was statistically significant. NC, P14 C3B mice. A p<0.01 (*) was
considered significant compared with the age-paired un-treated retina.
1080Chemokines are chemotactic cytokines acting through G-
protein coupled receptors. Elevated expression of chemokines
have been reported in ocular inflammation [26] and light-in-
duced retinal degeneration [27]. Recently, Zeng et al. observed
that several chemokines were up-regulated in rd mice, which
confirmed the intimate association of microglial activation and
chemokines secretion [5]. In the present study, we observed
that the expression of mRNA transcripts for MIP-1α, MIP-1β
and RANTES was up-regulated from P12, peaked at P17, and
declined to basal level by P28. Their expression was just cor-
respondingly increased and declined accompanying photore-
ceptor apoptosis, suggested that they might be mainly secreted
by apoptotic photoreceptor cells and play a major role in mi-
croglial activation and recruitment. The expression of mRNA
transcripts for MCP-1, MCP-3 and eotaxin was up-regulated
from P14 and peaked at P28, their expression was sustained at
a relatively high level until P90, afterwards their expression
was declined. The up-regulation of MCP-1, MCP-3 and eotaxin
was coincided with the microglial activation, which suggested
that activated microglia were the main source of these
chemokines, and these chemokines might play a major role in
recruiting more microglia to the lesion site.. It was notewor-
thy that the normal retina constitutively expressed detectable
levels of RANTES and eotaxin. These two chemokines rec-
ognized the same receptor CCR3 (CC chemokine receptor 3)
[28]. Previous studies demonstrated that RANTES regulated
the growth and survival of first-trimester forebrain astrocyte
[29]. We suggest that they were not only mediators of micro-
glial recruitment but they might also be regulators of retinal
development as suggested by Bakhiet et al. [29].
Minocycline has recently been shown to have remark-
able neuroprotective properties in models of neurodegeneration
[14,30]. Evidence suggests that this apparent neuroprotective
property is mainly through two separate mechanisms. The first
of these mechanisms was probably through direct anti-
apoptotic effect. Minocycline inhibited the caspase-3 activa-
tion [8] and inhibited the release of cytochrome C from the
mitochondria [31]. The second mechanism involved anti-in-
flammatory effects including preventing the activation and
migration of microglia [30], decreasing the induction of iNOS
expression [12], and reducing the cyclo-oxygenase-2 expres-
sion [32]. In the present study, we observed that minocycline
treatment reduced iNOS expression and delayed the initial
photoreceptor apoptosis in rds mice. Considering that NO
played an important role in the initial retinal degeneration in
rds mice, we suggested that minocyline treatment protect pho-
toreceptor apoptosis partly through iNOS-dependent mecha-
nism. However in the late stage of the disease, microglial ac-
tivation and photoreceptor apoptosis persisted after
minocycline treatment. The apoptotic photoreceptors produced
chemokines to activate and recruit retinal microglia to the le-
sion site. However the accumulation of activated microglia in
the ONL not only cleared the debris, but also secreted cyto-
toxic factors to exaggerate subsequent cone photoreceptor
death. RP is initiated with the loss of night vision due to rod
degeneration, and is followed by irreversible vision loss due
to cone degeneration. Cone loss is responsible for the main
visual handicap and its loss is indirect. Based on this study,
we believe microglial suppressive factors might provide a
beneficial role in these diseases.
ACKNOWLEDGEMENTS
 This work was supported in part by National Natural Science
Foundation of China (30600689, Dr Yang), Michael Panitch
Research Fund (Dr. Tso), RPB Foundation (Dr. Tso), and the
Oliver Birckhead Research Fund (Dr. Tso), and Research Fund
from Peking University Third Hospital (Dr. Yang).
REFERENCES
 1. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of
photoreceptor death in rd, rds, and rhodopsin mutant mice. Neu-
ron 1993; 11:595-605.
2. Sanyal S, De Ruiter A, Hawkins RK. Development and degenera-
tion of retina in rds mutant mice: light microscopy. J Comp
Neurol 1980; 194:193-207.
3. Roque RS, Imperial CJ, Caldwell RB. Microglial cells invade the
outer retina as photoreceptors degenerate in Royal College of
Surgeons rats. Invest Ophthalmol Vis Sci 1996; 37:196-203.
4. Thanos S. Sick photoreceptors attract activated microglia from the
ganglion cell layer: a model to study the inflammatory cascades
in rats with inherited retinal dystrophy. Brain Res 1992; 588:21-
8.
5. Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM, Tso MO. Identifi-
cation of sequential events and factors associated with micro-
glial activation, migration, and cytotoxicity in retinal degenera-
tion in rd mice. Invest Ophthalmol Vis Sci 2005; 46:2992-9.
6. Ng TF, Streilein JW. Light-induced migration of retinal microglia
into the subretinal space. Invest Ophthalmol Vis Sci 2001;
42:3301-10.
7. Hughes EH, Schlichtenbrede FC, Murphy CC, Sarra GM, Luthert
PJ, Ali RR, Dick AD. Generation of activated sialoadhesin-posi-
tive microglia during retinal degeneration. Invest Ophthalmol
Vis Sci 2003; 44:2229-34.
8. Hughes EH, Schlichtenbrede FC, Murphy CC, Broderick C, van
Rooijen N, Ali RR, Dick AD. Minocycline delays photorecep-
tor death in the rds mouse through a microglia-independent
mechanism. Exp Eye Res 2004; 78:1077-84.
9. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and
functional expression of an inducible nitric oxide synthase from
a murine macrophage cell line. J Biol Chem 1992; 267:6370-4.
10. Kim YJ, Hwang SY, Han IO. Insoluble matrix components of
glioma cells suppress LPS-mediated iNOS/NO induction in
microglia. Biochem Biophys Res Commun 2006; 347:731-8.
11. Nikodemova M, Duncan ID, Watters JJ. Minocycline exerts in-
hibitory effects on multiple mitogen-activated protein kinases
and IkappaBalpha degradation in a stimulus-specific manner in
microglia. J Neurochem 2006; 96:314-23.
12. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH,
Koistinaho J. A tetracycline derivative, minocycline, reduces
inflammation and protects against focal cerebral ischemia with
a wide therapeutic window. Proc Natl Acad Sci U S A 1999;
96:13496-500.
13. Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J.
Nitric oxide accelerates the onset and increases the severity of
experimental autoimmune uveoretinitis through an IFN-gamma-
dependent mechanism. J Immunol 1997; 159:5132-42.
14. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J,
Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH,
Friedlander RM. Minocycline inhibits caspase-1 and caspase-3
©2007 Molecular Vision Molecular Vision 2007; 13:1073-82 <http://www.molvis.org/molvis/v13/a117/>
1081expression and delays mortality in a transgenic mouse model of
Huntington disease. Nat Med 2000; 6:797-801.
15. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth
C, Choi DK, Ischiropoulos H, Przedborski S. Blockade of mi-
croglial activation is neuroprotective in the 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
J Neurosci 2002; 22:1763-71.
16. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW.
Targeting leukocyte MMPs and transmigration: minocycline as
a potential therapy for multiple sclerosis. Brain 2002; 125:1297-
308.
17. Zhang C, Lei B, Lam TT, Yang F, Sinha D, Tso MO.
Neuroprotection of photoreceptors by minocycline in light-in-
duced retinal degeneration. Invest Ophthalmol Vis Sci 2004;
45:2753-9.
18. Wu M, Kusukawa N. SDS agarose gels for analysis of proteins.
Biotechniques 1998; 24:676-8.
19. Kaufman PL, Gabelt BT. Cholinergic mechanisms and aqueous
humor dynamics. In: Drance S, Neufeld A, Van Buskirk E, edi-
tors. Applied pharmacology of the glaucomas. Baltimore: Wil-
liams and Wilkins; 1992. p. 64-92.
20. Miyachi E, Murakami M, Nakaki T. Arginine blocks gap junc-
tions between retinal horizontal cells. Neuroreport 1990; 1:107-
10.
21. Kurenny DE, Moroz LL, Turner RW, Sharkey KA, Barnes S.
Modulation of ion channels in rod photoreceptors by nitric ox-
ide. Neuron 1994; 13:315-24.
22. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK.
Cytokine-stimulated astrocytes damage human neurons via a
nitric oxide mechanism. Glia 1996; 16:276-84.
23. Cotinet A, Goureau O, Hicks D, Thillaye-Goldenberg B, de Kozak
Y. Tumor necrosis factor and nitric oxide production by retinal
Muller glial cells from rats exhibiting inherited retinal dystro-
phy. Glia 1997; 20:59-69.
24. Ehret-Hilberer S, Nullans G, Aunis D, Virmaux N. Mono ADP-
ribosylation of transducin catalyzed by rod outer segment ex-
tract. FEBS Lett 1992; 309:394-8.
25. Beckman JS, Crow JP. Pathological implications of nitric oxide,
superoxide and peroxynitrite formation. Biochem Soc Trans
1993; 21:330-4.
26. Foxman EF, Zhang M, Hurst SD, Muchamuel T, Shen D,
Wawrousek EF, Chan CC, Gery I. Inflammatory mediators in
uveitis: differential induction of cytokines and chemokines in
Th1- versus Th2-mediated ocular inflammation. J Immunol
2002; 168:2483-92.
27. Zhang C, Shen JK, Lam TT, Zeng HY, Chiang SK, Yang F, Tso
MO. Activation of microglia and chemokines in light-induced
retinal degeneration. Mol Vis 2005; 11:887-95.
28. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam
N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos
JC, Mackay CR. Cloning of the human eosinophil
chemoattractant, eotaxin. Expression, receptor binding, and func-
tional properties suggest a mechanism for the selective recruit-
ment of eosinophils. J Clin Invest 1996; 97:604-12.
29. Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel
WA, Seiger A, Andersson J. RANTES promotes growth and
survival of human first-trimester forebrain astrocytes. Nat Cell
Biol 2001; 3:150-7.
30. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection
against N-methyl-D-aspartate neurotoxicity by inhibiting mi-
croglia. J Immunol 2001; 166:7527-33.
31. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang
S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ,
Przedborski S, Kristal BS, Friedlander RM. Minocycline inhib-
its cytochrome c release and delays progression of amyotrophic
lateral sclerosis in mice. Nature 2002; 417:74-8.
32. Kim SS, Kong PJ, Kim BS, Sheen DH, Nam SY, Chun W. Inhibi-
tory action of minocycline on lipopolysaccharide-induced re-
lease of nitric oxide and prostaglandin E2 in BV2 microglial
cells. Arch Pharm Res 2004; 27:314-8.
©2007 Molecular Vision Molecular Vision 2007; 13:1073-82 <http://www.molvis.org/molvis/v13/a117/>
1082
The print version of this article was created on 9 July 2007. This reflects all typographical corrections and errata to the article through that date.
Details of any changes may be found in the online version of the article. α